Innovative Cellular Therapeutics Holdings Ltd

Ten-percent owner · LYEL

As of 2026-09-16, Innovative Cellular Therapeutics Holdings Ltd has 6 Form 4 transactions on record across 1 company — 6 in the trailing 12 months.

Everything this person has disclosed to the SEC on Form 4 — across every company they file for — reconstructed from the public record. A filing history, not a tip sheet.

Reconstructed holdings

Direct: $29.9MIndirect: $0$29.9Mas of 2026-09-16
  • Direct $29.9M
  • Indirect $0
LYELdirect2,774,980 sh$29.9M

Reconstructed from this person's own Form 4 filings — the total each filing reported owning afterward, priced at the close on the as-of date shown. A filed position can lag the real one.

Direct and indirect holdings (e.g. through a trust or fund) are tagged separately, as filed.

Trades by company

LYEL · 6 trades
2026-07-27: Other acquisition, 38,500 sh ($0)2026-07-27: Other acquisition, 44,000 sh ($0)2026-07-17: Sale, 10 sh ($137)2026-07-16: Sale, 10 sh ($137)2026-06-29: Other acquisition, 76,000 sh ($0)2026-06-15: Other acquisition, 66,500 sh ($0)

Filing ledger

DateCompanyActionShares @ priceValueOwnership ΔOwned afterFiling
2026-07-17LYELSale10 @ $13.70$137−0.0% of holding2,857,480Form 4
2026-07-16LYELSale10 @ $13.73$137−0.0% of holding2,857,490Form 4
4 award / exercise / gift records — not counted as purchases
DateCompanyActionSharesOwned afterFiling
2026-07-27LYELOther acquisition38,5002,818,980Form 4
2026-07-27LYELOther acquisition44,0002,774,980Form 4
2026-06-29LYELOther acquisition76,0002,857,500Form 4
2026-06-15LYELOther acquisition66,5002,933,500Form 4

Source: SEC Form 4 filings. Each row links to its original filing.

Research tool, not investment advice — historical frequencies, not recommendations. A product of Marovel Technologies LLC. Full terms.